Laryngoscope Asssited Lightwand Intubation

NCT ID: NCT01950702

Last Updated: 2014-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

168 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the success rate for intubation of laryngocope assisted lightwand intubation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Light wand intubation is well known for safety intubation in cervical injury patiets. Traditional method of using light wand can damage the supraglottic cavity by scooping the apparatus. The investigators try to evaluate the efficacy of laryngoscope assisted light wand intubation compared to traditional method of using light wand alone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Spine Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lightwand intubation

After standard total intravenous anesthesia using propofol and remifentanil continuous infusion, traditional lightwand intubation was done by pre-specified anesthesiologist who experienced more than 100 times of lightwand intubation.

Patient's head were fixed at neutral position during all intubation period.

Group Type ACTIVE_COMPARATOR

Lightwand intubation

Intervention Type PROCEDURE

After standard monitoring(EKG, pulse oximetry, NIBP), participants were induced with remifentanil and propofol continuous infusion, using targe-controlled infusion device with prexoygenation with 100% oxygen.

Manual in-line stabilization was applied with velcro during intubation to maintain neutral head position.

After 2min from administration of rocuronium, the clinician holds the wand similar to a pencil, stands directly behind the patient's head, inserts the device into the side of the mouth and sweeps the tip to the midline. After confirmation of precise location via clear light source on anterior neck, endotracheal tube was inserted and withdrawn lightwand.

Laryngoscope assisted lightwand intubation

After standard total intravenous anesthesia using propofol and remifentanil continuous infusion, lightwand intubation using specific device(Macintosh laryngosope, female:3/Male:4) was done by pre-specified anesthesiologist who experienced more than 100 times of laryngoscope assisted lightwand intubation.

Group Type EXPERIMENTAL

Laryngoscope assisted lightwand intubation

Intervention Type PROCEDURE

After standard monitoring(EKG, pulse oximetry, NIBP), participants were induced with remifentanil and propofol continuous infusion, using targe-controlled infusion device with prexoygenation with 100% oxygen.

Manual in-line stabilization was applied with velcro during intubation to maintain neutral head position.

The Macintosh laryngoscope (female: 3rd blade, male: 4th blade) was inserted into the oral cavity to provide direct view of the epiglottis and then the tip of the lightwand was placed below the epiglottis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laryngoscope assisted lightwand intubation

After standard monitoring(EKG, pulse oximetry, NIBP), participants were induced with remifentanil and propofol continuous infusion, using targe-controlled infusion device with prexoygenation with 100% oxygen.

Manual in-line stabilization was applied with velcro during intubation to maintain neutral head position.

The Macintosh laryngoscope (female: 3rd blade, male: 4th blade) was inserted into the oral cavity to provide direct view of the epiglottis and then the tip of the lightwand was placed below the epiglottis.

Intervention Type PROCEDURE

Lightwand intubation

After standard monitoring(EKG, pulse oximetry, NIBP), participants were induced with remifentanil and propofol continuous infusion, using targe-controlled infusion device with prexoygenation with 100% oxygen.

Manual in-line stabilization was applied with velcro during intubation to maintain neutral head position.

After 2min from administration of rocuronium, the clinician holds the wand similar to a pencil, stands directly behind the patient's head, inserts the device into the side of the mouth and sweeps the tip to the midline. After confirmation of precise location via clear light source on anterior neck, endotracheal tube was inserted and withdrawn lightwand.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

The Macintosh laryngoscope (female: 3rd blade, male: 4th blade) lightwand (Surch-Lite, Aaron Medical Industries, St. Petersburg, FL) Surch-Lite, Aaron Medical Industries, St. Petersburg, FL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient scheduled for cervical spine surgery under general anesthesia

Exclusion Criteria

* congenital or acquired abnormalities of the upper airway, tumours, polyps, trauma, abscesses, inflammation, or foreign bodies in the upper airway
* history of gastro-esophageal reflux disease, previous airway surgery, an increased risk of aspiration, coagulation disorders
* American Society of Anesthesiologists physical status ≥ 3
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hee-Pyoung Park

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hee-Pyung Park, MD PhD

Role: STUDY_DIRECTOR

Professor

Eugene Kim, MD

Role: PRINCIPAL_INVESTIGATOR

fellow

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University of Hospital

Seoul, Jongno-Gu, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hee-Pyung Park, MD PhD

Role: CONTACT

82-2-2072-2466

Eugene Kim, MD

Role: CONTACT

82-2-2072-2469

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hee-Pyung Park, MD PhD

Role: primary

82-2-2072-2466

Eugene Kim, MD

Role: backup

82-2-2072-2469

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

php3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.